03/26/2026 | Press release | Distributed by Public on 03/26/2026 14:57
TABLE OF CONTENTS
|
|
|
||
|
|
|||
|
Delaware
|
|
|
16-1434688
|
|
(State or other jurisdiction of incorporation or organization)
|
|
|
(I.R.S. Employer Identification Number)
|
|
|
|
|
|
|
|
|
|
|
|
Boris Dolgonos
Proskauer Rose LLP
Eleven Times Square
New York, New York 10036
(212) 969-3000
|
|
|
Cathy King
Chief Legal Officer and Corporate Secretary
PAR Technology Park
8383 Seneca Turnpike
New Hartford, New York 13413
(315) 738-0600
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Large accelerated filer
|
|
|
☒
|
|
|
Accelerated filer
|
|
|
☐
|
|
Non-accelerated filer
|
|
|
☐
|
|
|
Smaller reporting company
|
|
|
☐
|
|
|
|
|
|
Emerging growth company
|
|
|
☐
|
||
|
|
|
|
|
|
|
|
|
|
|
TABLE OF CONTENTS
|
•
|
a base prospectus which covers the offering, issuance and sale by us and/or the offering and sale by selling securityholders of the securities identified in the base prospectus from time to time in one or more offerings; and
|
|
•
|
a resale prospectus supplement relating to the possible resale by the selling securityholder named therein of up to a maximum of 1,810,222 shares of our common stock.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
ABOUT THIS PROSPECTUS
|
|
|
1
|
|
WHERE YOU CAN FIND MORE INFORMATION
|
|
|
2
|
|
INCORPORATION BY REFERENCE
|
|
|
3
|
|
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
|
|
|
4
|
|
ABOUT PAR TECHNOLOGY CORPORATION
|
|
|
6
|
|
RISK FACTORS
|
|
|
7
|
|
USE OF PROCEEDS
|
|
|
8
|
|
DESCRIPTION OF CAPITAL STOCK
|
|
|
9
|
|
DESCRIPTION OF DEBT SECURITIES
|
|
|
12
|
|
DESCRIPTION OF WARRANTS
|
|
|
19
|
|
SELLING STOCKHOLDERS
|
|
|
20
|
|
PLAN OF DISTRIBUTION
|
|
|
21
|
|
LEGAL MATTERS
|
|
|
23
|
|
EXPERTS
|
|
|
23
|
|
|
|
|
|
|
|
|
|
|
|
ABOUT THIS PROSPECTUS SUPPLEMENT
|
|
|
S-1
|
|
WHERE YOU CAN FIND MORE INFORMATION
|
|
|
S-2
|
|
INCORPORATION BY REFERENCE
|
|
|
S-3
|
|
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
|
|
|
S-4
|
|
ABOUT PAR TECHNOLOGY CORPORATION
|
|
|
S-6
|
|
RISK FACTORS
|
|
|
S-7
|
|
USE OF PROCEEDS
|
|
|
S-8
|
|
SELLING STOCKHOLDER
|
|
|
S-9
|
|
PLAN OF DISTRIBUTION
|
|
|
S-10
|
|
VALIDITY OF THE SECURITIES
|
|
|
S-12
|
|
EXPERTS
|
|
|
S-12
|
|
|
|
|
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
•
|
our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as filed with the SEC on February 26, 2026;
|
|
•
|
the information responsive to part III of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, provided in our Proxy Statement on Schedule 14A, filed with the SEC on April 17, 2025 and as supplemented by the additional definitive proxy soliciting materials filed with the SEC on May 21, 2025;
|
|
•
|
our Current Reports on Form 8-K as filed with the SEC on January 15, 2026, January 26, 2026 (Item 3.02 only and as amended by our Current Report on Form 8-K/A filed on March 24, 2026), February 26, 2026 (Item 8.01 only), and March 17, 2026; and
|
|
•
|
the description of our common stock included in Exhibit 4.6 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed with the SEC on March 3, 2025 and including any amendments and reports filed for the purpose of updating such description.
|
TABLE OF CONTENTS
|
•
|
our plans, strategies, and objectives for future operations and the growth of our business, including our service and product offerings, our go-to-market strategies, and the expected development, demand, performance, market share, and competitive performance of our products and services;
|
|
•
|
our ability to achieve and sustain profitability;
|
|
•
|
our future revenues, gross margins, expenses, cash flows, and other financial measures;
|
|
•
|
annual recurring revenue (ARR), active sites, subscription service gross margins, net loss, net income (loss) per share, and other key performance indicators and non-GAAP financial measures;
|
|
•
|
the availability and terms of product and component supplies for our hardware products;
|
|
•
|
the timing and expected benefits of acquisitions, divestitures, and capital markets transactions;
|
|
•
|
our human capital strategies and engagement;
|
|
•
|
macroeconomic trends, geopolitical events, tariffs, and trade disputes and the expected impact of those trends and events on our business, financial condition, results of operations, and cash flows;
|
|
•
|
claims, disputes, or other litigation matters; and
|
|
•
|
assumptions underlying any of the foregoing.
|
|
•
|
our ability to successfully develop, acquire, and transition new products and services, while enhancing existing ones to meet evolving customer needs and emerging technological trends, including our effective use of artificial intelligence (AI) in product development and integration of AI tools into our product and service offerings;
|
|
•
|
our ability to add and maintain active sites;
|
|
•
|
our ability to retain and add integration partners;
|
|
•
|
macroeconomic trends, such as the effects of inflation, recession, interest rate fluctuations, and changes in consumer confidence and discretionary spending; and geopolitical events affecting countries where we operate or our customers or suppliers operate;
|
|
•
|
our ability to retain and manage suppliers, secure alternative suppliers, and manage inventory levels and costs, navigate manufacturing disruptions or logistics challenges, shipping delays and shipping costs;
|
|
•
|
the impact of changes in import/export regulations, including tariffs, and trade disputes between the United States and other countries where we operate or our customers or suppliers operate;
|
|
•
|
the effects, costs, and timing of acquisitions, divestitures, and capital markets transactions;
|
|
•
|
our ability to integrate acquisitions into our operations and the timing, complexity, and costs associated with integrations;
|
|
•
|
our ability to attract, develop, and retain qualified employees to develop and expand our business, execute product installations, and respond to customer service level needs;
|
TABLE OF CONTENTS
|
•
|
the protection of our intellectual property;
|
|
•
|
our ability to generate sufficient cash flow or access additional financing sources as needed to repay outstanding debts, including amounts owed under our outstanding convertible notes;
|
|
•
|
legal, reputational, and financial risks if we fail to protect customer and/or our data from security breaches and/or cyber attacks;
|
|
•
|
the impact of future pandemics, epidemics, or other outbreaks of disease;
|
|
•
|
changes in estimates and assumptions we make in connection with the preparation of our financial statements, or in building our business and operations plan and in executing our strategies;
|
|
•
|
our ability to maintain proper and effective internal control over financial reporting;
|
|
•
|
our ability to execute our business and operations plan, implement our strategies, and manage our business continuity risks, including service interruptions and disruptions or delays in product assembly and fulfillment;
|
|
•
|
potential impacts, liabilities, and costs from pending or potential investigations, claims, and disputes; and
|
|
•
|
other factors, risks, trends, and uncertainties that could cause our actual results to differ materially from those expressed in or implied by forward-looking statements contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, our subsequent Quarterly Reports on Form 10-Q, and our other filings with the SEC and the other information included or incorporated by reference herein and in any accompanying prospectus supplement.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
•
|
the title and ranking of the debt securities (including the terms of any subordination provisions);
|
|
•
|
the price or prices (expressed as a percentage of the principal amount) at which we will sell the debt securities;
|
|
•
|
any limit on the aggregate principal amount of the debt securities;
|
|
•
|
the date or dates on which the principal of the securities of the series is payable;
|
|
•
|
the rate or rates (which may be fixed or variable) per annum or the method used to determine the rate or rates (including any commodity, commodity index, stock exchange index or financial index) at which the debt securities will bear interest, the date or dates, if any, from which interest will accrue, the date or dates, if any, on which interest will commence and be payable and any regular record date for the interest payable on any interest payment date;
|
|
•
|
the place or places where principal of, and interest, if any, on the debt securities will be payable (and the method of such payment), where the securities of such series may be surrendered for registration of transfer or exchange, and where notices and demands to us in respect of the debt securities may be delivered;
|
|
•
|
the period or periods within which, the price or prices at which and the terms and conditions upon which we may redeem the debt securities;
|
|
•
|
any obligation we have to redeem or purchase the debt securities pursuant to any sinking fund or analogous provisions or at the option of a holder of debt securities and the period or periods within which, the price or prices at which and in the terms and conditions upon which debt securities of the series will be redeemed or purchased, in whole or in part, pursuant to such obligation;
|
TABLE OF CONTENTS
|
•
|
the dates on which and the price or prices at which we will repurchase debt securities at the option of the holders of debt securities and other detailed terms and provisions of these repurchase obligations;
|
|
•
|
the denominations in which the debt securities will be issued, if other than denominations of $1,000 and any integral multiple thereof;
|
|
•
|
whether the debt securities will be issued in the form of certificated debt securities or global debt securities;
|
|
•
|
the portion of principal amount of the debt securities payable upon declaration of acceleration of the maturity date, if other than the principal amount;
|
|
•
|
the currency of denomination of the debt securities, which may be United States Dollars or any foreign currency, and if such currency of denomination is a composite currency, the agency or organization, if any, responsible for overseeing such composite currency;
|
|
•
|
the designation of the currency, currencies or currency units in which payment of principal of, premium and interest on the debt securities will be made;
|
|
•
|
if payments of principal of, premium or interest on the debt securities will be made in one or more currencies or currency units other than that or those in which the debt securities are denominated, the manner in which the exchange rate with respect to these payments will be determined;
|
|
•
|
the manner in which the amounts of payment of principal of, premium, if any, or interest on the debt securities will be determined, if these amounts may be determined by reference to an index based on a currency or currencies or by reference to a commodity, commodity index, stock exchange index or financial index;
|
|
•
|
any provisions relating to any security provided for the debt securities;
|
|
•
|
any addition to, deletion of or change in the Events of Default described in this prospectus or in the indenture with respect to the debt securities and any change in the acceleration provisions described in this prospectus or in the indenture with respect to the debt securities;
|
|
•
|
any addition to, deletion of or change in the covenants described in this prospectus or in the indenture with respect to the debt securities;
|
|
•
|
any depositaries, interest rate calculation agents, exchange rate calculation agents or other agents with respect to the debt securities;
|
|
•
|
any provisions relating to conversion or exchange of any debt securities of such series, including, if applicable, the conversion or exchange price and period, provisions as to whether conversion or exchange will be mandatory, at the option of the holders thereof or at our option, the events requiring an adjustment of the conversion or exchange price and provisions affecting conversion or exchange;
|
|
•
|
any other terms of the debt securities (which may supplement, modify or delete any provision of the indenture as it applies to that series), including any terms that may be required under applicable law or regulations or advisable in connection with the marketing of the securities; and
|
|
•
|
whether any of our direct or indirect subsidiaries will guarantee the debt securities of that series, including the terms of subordination, if any, of such guarantees. (Section 2.2)
|
TABLE OF CONTENTS
|
•
|
we are the surviving entity or the successor person (if other than PAR) is a corporation, partnership, trust or other entity organized and validly existing under the laws of any U.S. domestic jurisdiction and expressly assumes our obligations on the debt securities and under the indenture; and
|
|
•
|
immediately after giving effect to the transaction, no Default or Event of Default, shall have occurred and be continuing.
|
|
•
|
default in the payment of any interest upon any debt security of that series when it becomes due and payable, and continuance of such default for a period of 30 days (unless the entire amount of the payment is deposited by us with the trustee or with a paying agent prior to the expiration of the 30-day period);
|
|
•
|
default in the payment of principal of any security of that series at its maturity;
|
|
•
|
default in the performance or breach of any other covenant or warranty by us in the indenture (other than defaults pursuant to the foregoing or pursuant to a covenant or warranty that has been included in the
|
TABLE OF CONTENTS
|
•
|
certain voluntary or involuntary events of bankruptcy, insolvency or reorganization of PAR; or
|
|
•
|
any other Event of Default provided with respect to debt securities of that series that is described in the applicable prospectus supplement. (Section 6.1)
|
|
•
|
that holder has previously given to the trustee written notice of a continuing Event of Default with respect to debt securities of that series; and
|
|
•
|
the holders of not less than 25% in principal amount of the outstanding debt securities of that series have made written request in respect of that Event of Default, and offered indemnity or security satisfactory to the trustee, to the trustee to institute the proceeding as trustee, and the trustee has not received from the holders of not less than a majority in principal amount of the outstanding debt securities of that series a direction inconsistent with that request and has failed to institute the proceeding within 60 days. (Section 6.7)
|
TABLE OF CONTENTS
|
•
|
to cure any ambiguity, defect or inconsistency;
|
|
•
|
to comply with covenants in the indenture described above under the heading "Consolidation, Merger and Sale of Assets";
|
|
•
|
to provide for uncertificated securities in addition to or in place of certificated securities;
|
|
•
|
to add guarantees with respect to debt securities of any series or secure debt securities of any series;
|
|
•
|
to surrender any of our rights or powers under the indenture;
|
|
•
|
to add covenants or events of default for the benefit of the holders of debt securities of any series;
|
|
•
|
to comply with the applicable procedures of the applicable depositary;
|
|
•
|
to make any change that does not adversely affect the rights of any holder of debt securities;
|
|
•
|
to provide for the issuance of and establish the form and terms and conditions of debt securities of any series as permitted by the indenture;
|
|
•
|
to effect the appointment of a successor trustee with respect to the debt securities of any series and to add to or change any of the provisions of the indenture to provide for or facilitate administration by more than one trustee;
|
|
•
|
to comply with requirements of the SEC in order to effect or maintain the qualification of the indenture under the Trust Indenture Act; or
|
|
•
|
to conform the indenture or the terms of the debt securities to any terms set forth in this prospectus or an applicable prospectus supplement. (Section 9.1)
|
|
•
|
reduce the principal amount of debt securities whose holders must consent to an amendment, supplement or waiver;
|
|
•
|
reduce the rate of or extend the time for payment of interest (including default interest) on any debt security;
|
|
•
|
reduce the principal of or premium on or change the fixed maturity of any debt security or reduce the amount of, or postpone the date fixed for, the payment of any sinking fund or analogous obligation;
|
|
•
|
reduce the principal amount of discount securities payable upon acceleration of maturity;
|
TABLE OF CONTENTS
|
•
|
waive a default in the payment of the principal of, premium or interest on any debt security (except a rescission of acceleration of the debt securities of any series by the holders of at least a majority in principal amount of the then outstanding debt securities of that series and a waiver of the payment default that resulted from such acceleration);
|
|
•
|
make the principal of or premium or interest on any debt security payable in any currency other than that stated in the debt security;
|
|
•
|
make any change to certain provisions of the indenture relating to, among other things, the right of holders of debt securities to receive payment of the principal of, premium and interest on those debt securities and to institute suit for the enforcement of any such payment and to waivers or amendments; or
|
|
•
|
waive a redemption payment with respect to any debt security. (Section 9.3)
|
|
•
|
we may omit to comply with the covenant described under the heading "Consolidation, Merger and Sale of Assets" and certain other covenants set forth in the indenture, as well as any additional covenants which may be set forth in the applicable prospectus supplement; and
|
|
•
|
any omission to comply with those covenants will not constitute a Default or an Event of Default with respect to the debt securities of that series ("covenant defeasance").
|
|
•
|
depositing with the trustee money and/or U.S. government obligations or, in the case of debt securities denominated in a single currency other than U.S. Dollars, government obligations of the government that issued or caused to be issued such currency, that, through the payment of interest and principal in accordance with their terms, will provide money in an amount sufficient in the opinion of a nationally
|
TABLE OF CONTENTS
|
•
|
delivering to the trustee an opinion of counsel to the effect that the beneficial owners of the debt securities of that series will not recognize income, gain or loss for United States federal income tax purposes as a result of the deposit and related covenant defeasance and will be subject to United States federal income tax on the same amounts and in the same manner and at the same times as would have been the case if the deposit and related covenant defeasance had not occurred. (Section 8.4)
|
TABLE OF CONTENTS
|
•
|
the specific designation and aggregate number of, and the offering price at which we will issue, the warrants;
|
|
•
|
the currency or currency units in which the offering price, if any, and the exercise price are payable;
|
|
•
|
the date on which the right to exercise the warrants will begin and the date on which that right will expire or, if you may not continuously exercise the warrants throughout that period, the specific date or dates on which you may exercise the warrants;
|
|
•
|
whether the warrants will be issued in definitive or global form or in any combination of these forms;
|
|
•
|
any applicable material U.S. federal income tax consequences;
|
|
•
|
the identity of the warrant agent for the warrants and of any other depositaries, execution or paying agents, transfer agents, registrars or other agents;
|
|
•
|
the proposed listing, if any, of the warrants or any securities purchasable upon exercise of the warrants on any securities exchange;
|
|
•
|
the designation and terms of any equity securities purchasable upon exercise of the warrants;
|
|
•
|
the designation, aggregate principal amount, currency and terms of any debt securities that may be purchased upon exercise of the warrants;
|
|
•
|
if applicable, the designation and terms of the preferred stock with which the warrants are issued and the number of warrants issued with each security;
|
|
•
|
the number of shares of common stock or preferred stock purchasable upon exercise of a warrant and the price at which those shares may be purchased;
|
|
•
|
if applicable, the minimum or maximum amount of the warrants that may be exercised at any one time;
|
|
•
|
information with respect to book-entry procedures, if any;
|
|
•
|
the anti-dilution provisions of, and other provisions for changes to or adjustment in the exercise price of, the warrants, if any;
|
|
•
|
any redemption or call provisions; and
|
|
•
|
any additional terms of the warrants, including terms, procedures and limitations relating to the exchange or exercise of the warrants.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
|
•
|
through underwriters;
|
|
•
|
through dealers (acting as agents or principals);
|
|
•
|
through brokers;
|
|
•
|
in "at the market" offerings, as defined in Rule 415 under the Securities Act, including sales made directly on a national securities exchange or sales made through a market maker other than on an exchange;
|
|
•
|
through agents;
|
|
•
|
directly to one or more purchasers, on a negotiated basis or otherwise; or
|
|
•
|
through a combination of any of these methods or any other method permitted by law.
|
|
•
|
at a fixed price, or prices, which may be changed from time to time;
|
|
•
|
on any stock exchange, market, or trading facility on which the securities are traded or in private transactions;
|
|
•
|
at market prices prevailing at the time of sale;
|
|
•
|
at prices related to such prevailing market prices; or
|
|
•
|
at negotiated prices.
|
|
•
|
the name or names of the agent or any underwriters;
|
|
•
|
the public offering or purchase price and the proceeds we will receive from the sale of the securities;
|
|
•
|
any discounts and commissions to be allowed or re-allowed or paid to the agent or underwriters;
|
|
•
|
all other items constituting underwriting compensation;
|
|
•
|
any over-allotment options under which underwriters may purchase additional securities from us;
|
|
•
|
any discounts and commissions to be allowed or re-allowed or paid to dealers; and
|
|
•
|
any exchanges on which the securities will be listed.
|
TABLE OF CONTENTS
|
•
|
the purchase by an institution of the securities covered under that contract shall not at the time of delivery be prohibited under the laws of the jurisdiction to which that institution is subject; and
|
|
•
|
if the securities are also being sold to underwriters acting as principals for their own account, the underwriters shall have purchased such securities not sold for delayed delivery. The underwriters and other persons acting as our agents will not have any responsibility in respect of the validity or performance of delayed delivery contracts.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
ABOUT THIS PROSPECTUS SUPPLEMENT
|
|
|
S-1
|
|
WHERE YOU CAN FIND MORE INFORMATION
|
|
|
S-2
|
|
INCORPORATION BY REFERENCE
|
|
|
S-3
|
|
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
|
|
|
S-4
|
|
ABOUT PAR TECHNOLOGY CORPORATION
|
|
|
S-6
|
|
RISK FACTORS
|
|
|
S-7
|
|
USE OF PROCEEDS
|
|
|
S-8
|
|
SELLING STOCKHOLDER
|
|
|
S-9
|
|
PLAN OF DISTRIBUTION
|
|
|
S-10
|
|
VALIDITY OF THE SECURITIES
|
|
|
S-12
|
|
EXPERTS
|
|
|
S-12
|
|
|
|
|
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
•
|
our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, as filed with the SEC on February 26, 2026;
|
|
•
|
the information responsive to part III of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, provided in our Proxy Statement on Schedule 14A, filed with the SEC on April 17, 2025 and as supplemented by the additional definitive proxy soliciting materials filed with the SEC on May 21, 2025;
|
|
•
|
our Current Reports on Form 8-K as filed with the SEC on January 15, 2026, January 26, 2026 (Item 3.02 only and as amended by our Current Report on Form 8-K/A filed on March 24, 2026), February 26, 2026 (Item 8.01 only), and March 17, 2026; and
|
|
•
|
the description of our common stock included in Exhibit 4.6 to our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 filed with the SEC on March 3, 2025 and including any amendments and reports filed for the purpose of updating such description.
|
TABLE OF CONTENTS
|
•
|
our plans, strategies, and objectives for future operations and the growth of our business, including our service and product offerings, our go-to-market strategies, and the expected development, demand, performance, market share, and competitive performance of our products and services;
|
|
•
|
our ability to achieve and sustain profitability;
|
|
•
|
our future revenues, gross margins, expenses, cash flows, and other financial measures;
|
|
•
|
annual recurring revenue (ARR), active sites, subscription service gross margins, net loss, net income (loss) per share, and other key performance indicators and non-GAAP financial measures;
|
|
•
|
the availability and terms of product and component supplies for our hardware products;
|
|
•
|
the timing and expected benefits of acquisitions, divestitures, and capital markets transactions;
|
|
•
|
our human capital strategies and engagement;
|
|
•
|
macroeconomic trends, geopolitical events, tariffs, and trade disputes and the expected impact of those trends and events on our business, financial condition, results of operations, and cash flows;
|
|
•
|
claims, disputes, or other litigation matters; and
|
|
•
|
assumptions underlying any of the foregoing.
|
|
•
|
our ability to successfully develop, acquire, and transition new products and services, while enhancing existing ones to meet evolving customer needs and emerging technological trends, including our effective use of artificial intelligence (AI) in product development and integration of AI tools into our product and service offerings;
|
|
•
|
our ability to add and maintain active sites;
|
|
•
|
our ability to retain and add integration partners;
|
|
•
|
macroeconomic trends, such as the effects of inflation, recession, interest rate fluctuations, and changes in consumer confidence and discretionary spending; and geopolitical events affecting countries where we operate or our customers or suppliers operate;
|
|
•
|
our ability to retain and manage suppliers, secure alternative suppliers, and manage inventory levels and costs, navigate manufacturing disruptions or logistics challenges, shipping delays and shipping costs;
|
|
•
|
the impact of changes in import/export regulations, including tariffs, and trade disputes between the United States and other countries where we operate or our customers or suppliers operate;
|
|
•
|
the effects, costs, and timing of acquisitions, divestitures, and capital markets transactions;
|
|
•
|
our ability to integrate acquisitions into our operations and the timing, complexity, and costs associated with integrations;
|
TABLE OF CONTENTS
|
•
|
our ability to attract, develop, and retain qualified employees to develop and expand our business, execute product installations, and respond to customer service level needs;
|
|
•
|
the protection of our intellectual property;
|
|
•
|
our ability to generate sufficient cash flow or access additional financing sources as needed to repay outstanding debts, including amounts owed under our outstanding convertible notes;
|
|
•
|
legal, reputational, and financial risks if we fail to protect customer and/or our data from security breaches and/or cyber attacks;
|
|
•
|
the impact of future pandemics, epidemics, or other outbreaks of disease;
|
|
•
|
changes in estimates and assumptions we make in connection with the preparation of our financial statements, or in building our business and operations plan and in executing our strategies;
|
|
•
|
our ability to maintain proper and effective internal control over financial reporting;
|
|
•
|
our ability to execute our business and operations plan, implement our strategies, and manage our business continuity risks, including service interruptions and disruptions or delays in product assembly and fulfillment;
|
|
•
|
potential impacts, liabilities, and costs from pending or potential investigations, claims, and disputes; and
|
|
•
|
other factors, risks, trends, and uncertainties that could cause our actual results to differ materially from those expressed in or implied by forward-looking statements contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, our subsequent Quarterly Reports on Form 10-Q, and our other filings with the SEC and the other information included or incorporated by reference herein.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Name of Selling Stockholder
|
|
|
Number of
Shares of
Common
Stock
Beneficially
Owned
Prior to this
Offering
|
|
|
Percent of
Outstanding
Common
Stock
Beneficially
Owned Prior to
this Offering
|
|
|
Number of
Shares of
Common
Stock
Offered
Pursuant
to this
Prospectus
|
|
|
Number of
Shares
Beneficially
Owned
After Sale
of Shares
|
|
|
Percent of
Outstanding
Common
Stock
Beneficially
Owned After
Sale of
Shares
|
|
Cardlytics, Inc.(1)
|
|
|
1,810,222
|
|
|
4.4%
|
|
|
1,810,222
|
|
|
-
|
|
|
-%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Cardlytics, Inc. is a publicly traded company listed on The Nasdaq Stock Market LLC. The principal business address of Cardlytics, Inc. is 675 Ponce de Leon Avenue NE, Suite 4100, Atlanta, Georgia, 30308.
|
TABLE OF CONTENTS
|
•
|
through the New York Stock Exchange or any other securities exchange that quotes the common stock;
|
|
•
|
in the over-the-counter market;
|
|
•
|
in underwritten transaction, exchange distributions and/or secondary distributions;
|
|
•
|
in transactions other than on those exchanges or in the over-the-counter market (including negotiated transactions and other private transactions);
|
|
•
|
in short sales (sales of shares completed by delivery of borrowed stock) of the common stock, in transactions to cover short sales or otherwise in connection with short sales;
|
|
•
|
by pledge to secure debts and other obligations or on foreclosure of a pledge;
|
|
•
|
through put or call options, including the writing of exchange-traded call options, or other hedging transactions related to the common stock;
|
|
•
|
in a combination of any of the above transactions; or
|
|
•
|
any other method permitted pursuant to applicable law.
|
|
•
|
enter into transactions with a broker-dealer or any other person in connection with which such broker-dealer or other person will engage in short sales of common stock, in which case such broker-dealer or other person may use shares of common stock received from the selling stockholder to close out its short positions;
|
|
•
|
sell common stock short itself and redeliver shares offered by this prospectus supplement to close out its short positions or to close out stock loans incurred in connection with its short positions;
|
|
•
|
enter into option or other types of transactions that require the selling stockholder to deliver common stock to a broker-dealer or any other person, who will then resell or transfer the common stock under this prospectus supplement; or
|
|
•
|
loan or pledge the common stock to a broker-dealer or any other person, who may sell the loaned shares or, in an event of default in the case of a pledge, sell the pledged shares under this prospectus supplement.
|
TABLE OF CONTENTS
|
•
|
a block trade in which a broker-dealer or other person may resell a portion of the block, as principal or agent, in order to facilitate the transaction;
|
|
•
|
purchases by a broker-dealer or other person, as principal, and resale by the broker-dealer or other person for its account; or
|
|
•
|
ordinary brokerage transactions and transactions in which a broker solicits purchasers.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
TABLE OF CONTENTS
|
Item 14.
|
Other Expenses of Issuance and Distribution.
|
|
|
|
|
|
|
|
|
Amount to Be Paid
|
|
|
SEC registration fee(1)
|
|
|
$3,434.89
|
|
Printing and engraving(2)
|
|
|
|
|
Accounting services(2)
|
|
|
|
|
Legal fees of registrant's counsel(2)
|
|
|
|
|
Transfer agent's, trustee's and depositary's fees and expenses(2)
|
|
|
|
|
Miscellaneous(2)
|
|
|
|
|
Total(2)
|
|
|
$
|
|
|
|
|
|
|
(1)
|
Represents registration fee applicable to amount included in the prospectus supplement contained in the registration statement, for 1,810,222 shares of common stock to be sold by the selling stockholder named therein. Additional registration fees deferred in reliance upon Rules 456(b) and 457(r) under the Securities Act..
|
|
(2)
|
These fees and expenses are calculated based on the securities offered and the number of issuances and accordingly are not estimated at this time and will be reflected in the applicable prospectus supplement.
|
|
Item 15.
|
Indemnification of Directors and Officers.
|
TABLE OF CONTENTS
TABLE OF CONTENTS
|
Item 16.
|
Exhibits.
|
|
|
|
|
|
|
Exhibit No.
|
|
|
Description
|
|
1.1*
|
|
|
Form of Underwriting Agreement
|
|
|
|
Restated Certificate of Incorporation (filed as Exhibit 3.2 to the Registrant's Current Report on Form 8-K (File No. 001-09720) on June 3, 2025)
|
|
|
|
|
Amended and Restated Bylaws (filed as Exhibit 3.3 to the Registrant's Curren Report on Form 8-K (File No. 001-09720) filed on June 3, 2025)
|
|
|
|
|
Specimen Certificate for shares of common stock (filed as Exhibit 4 to the Registrant's Registration Statement Form S-2 SEC on May 20, 1996)
|
|
|
4.4
|
|
|
Form of Indenture
|
|
4.5*
|
|
|
Form of Debt Security
|
|
4.6*
|
|
|
Form of Warrant Agreement
|
|
5.1
|
|
|
Opinion of Proskauer Rose LLP
|
|
5.2
|
|
|
Opinion of Proskauer Rose LLP
|
|
23.1
|
|
|
Consent of Deloitte & Touche LLP, independent registered public accounting firm
|
|
23.2
|
|
|
Consent of Proskauer Rose LLP (included in Exhibit 5.1)
|
|
23.3
|
|
|
Consent of Proskauer Rose LLP (included in Exhibit 5.2)
|
|
24.1
|
|
|
Powers of Attorney (included in the signature pages to the Registration Statement)
|
|
25.1
|
|
|
Statement of Eligibility on Form T-1 under the Trust Indenture Act of 1939, as amended, of the Trustee under the Indenture
|
|
107
|
|
|
Filing Fee Table
|
|
|
|
|
|
|
*
|
To be filed by amendment or by a Current Report on Form 8-K.
|
|
Item 17.
|
Undertakings.
|
|
(a)(1)
|
To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:
|
|
(i)
|
to include any prospectus required by Section 10(a)(3) of the Securities Act of 1933, as amended (the "Securities Act");
|
|
(ii)
|
to reflect in the prospectus any facts or events arising after the effective date of this registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in this registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the "Filing Fee Tables" table in the effective registration statement; and
|
|
(iii)
|
to include any material information with respect to the plan of distribution not previously disclosed in this registration statement or any material change to such information in this registration statement;
|
TABLE OF CONTENTS
|
(2)
|
That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at the time shall be deemed to be the initial bona fide offering thereof.
|
|
(3)
|
To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
|
|
(4)
|
That, for the purpose of determining liability under the Securities Act to any purchaser:
|
|
(i)
|
each prospectus filed by the Registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and
|
|
(ii)
|
each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5) or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii) or (x) for the purpose of providing the information required by Section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof; provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date.
|
|
(5)
|
That, for the purpose of determining liability of the Registrant under the Securities Act to any purchaser in the initial distribution of the securities, the undersigned Registrant undertakes that in a primary offering of securities of such undersigned Registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, such undersigned Registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:
|
|
(i)
|
any preliminary prospectus or prospectus of such undersigned Registrant relating to the offering required to be filed pursuant to Rule 424;
|
|
(ii)
|
any free writing prospectus relating to the offering prepared by or on behalf of such undersigned Registrant or used or referred to by such undersigned Registrant;
|
|
(iii)
|
the portion of any other free writing prospectus relating to the offering containing material information about such undersigned Registrant or its securities provided by or on behalf of such undersigned Registrant; and
|
|
(iv)
|
any other communication that is an offer in the offering made by such undersigned Registrant to the purchaser.
|
|
(6)
|
That, for purposes of determining any liability under the Securities Act:
|
|
(i)
|
the information omitted from the form of prospectus filed as part of the registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the Registrant pursuant to Rule 424(b)(1) or (4) or 497(h) under the Securities Act shall be deemed to be part of the registration statement as of the time it was declared effective; and
|
|
(ii)
|
each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
|
TABLE OF CONTENTS
|
(b)
|
The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant's annual report pursuant to Section 13(a) or 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in this registration statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
|
|
(c)
|
The undersigned Registrant hereby undertakes to file an application for the purpose of determining the eligibility of the trustee to act under subsection (a) of Section 310 of the Trust Indenture Act in accordance with the rules and regulations prescribed by the Commission under Section 305(b)(2) of the Trust Indenture Act.
|
|
(d)
|
Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of any Registrant pursuant to the indemnification provisions described herein, or otherwise, each Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of such Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, such Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
|
TABLE OF CONTENTS
|
|
|
|
|
|||
|
|
|
PAR TECHNOLOGY CORPORATION
|
||||
|
|
|
|
|
|||
|
|
|
By:
|
|
|
/s/ Savneet Singh
|
|
|
|
|
Name:
|
|
|
Savneet Singh
|
|
|
|
|
Title:
|
|
|
Chief Executive Officer & President
(Principal Executive Officer)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Signature
|
|
|
Title
|
|
|
Date
|
|
|
|
|
|
|||
|
|
|
|
|
|||
|
/s/ Savneet Singh
|
|
|
Chief Executive Officer, President & Director (Principal Executive Officer)
|
|
|
March 26, 2026
|
|
Savneet Singh
|
|
|||||
|
|
|
|
|
|||
|
/s/ Bryan A. Menar
|
|
|
Chief Financial Officer
(Principal Financial)
|
|
|
March 26, 2026
|
|
Bryan A. Menar
|
|
|||||
|
|
|
|
||||
|
/s/ Michael A. Steenberge
|
|
|
Senior Vice President, Finance & Transformation
(Principal Accounting Officer)
|
|
|
March 26, 2026
|
|
Michael A. Steenberge
|
|
|||||
|
|
|
|
||||
|
/s/ Linda Marie Crawford
|
|
|
Director
|
|
|
March 26, 2026
|
|
Linda Marie Crawford
|
|
|||||
|
|
|
|
||||
|
/s/ Keith E. Pascal
|
|
|
Director
|
|
|
March 26, 2026
|
|
Keith E. Pascal
|
|
|||||
|
|
|
|
||||
|
/s/ Douglas G. Rauch
|
|
|
Director
|
|
|
March 26, 2026
|
|
Douglas G. Rauch
|
|
|||||
|
|
|
|
||||
|
/s/ Cynthia A. Russo
|
|
|
Director
|
|
|
March 26, 2026
|
|
Cynthia A. Russo
|
|
|||||
|
|
|
|
||||
|
/s/ Narinder Singh
|
|
|
Director
|
|
|
March 26, 2026
|
|
Narinder Singh
|
|
|||||
|
|
|
|
|
|||
|
/s/ James C. Stoffel
|
|
|
Director
|
|
|
March 26, 2026
|
|
James C. Stoffel
|
|
|||||
|
|
|
|
|
|
|
|